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Background
Myocarditis subsumes a variety of entities, including
diverse courses from complete healing to dilated cardio-
myopathy with severe myocardial fibrosis. T1-mapping
cardiovascular magnetic resonance (CMR) has the ability
to quantify myocardial extracellular volume (ECV) as a
surrogate of acute and chronic myocardial injury. Galec-
tin-3 is an important mediator of fibrogenesis and con-
tributes to adverse left ventricular (LV) remodeling. This
study evaluated, if myocardial ECV expansion is linked
to Galectin-3 levels in patients with myocarditis.
Methods
Galectin-3 blood levels were measured in 20 patients
with myocarditis using a commercially available chemi-
luminescent microparticle immunoassay (ARCHITECT
Galectin-3, Abbott Germany). T1 quantification was
performed at 1.5 Tesla using the modified Look-Locker
inversion-recovery (MOLLI) sequence before and 15
minutes after administration of 0.075 mmol/kg gadoli-
nium-BOPTA. Global myocardial ECV was calculated
from T1 maps generated by a dedicated plug-in written
for the OsiriX software.
Results
Median Galectin-3 level was 17.4 ng/mL (interquartile
range 13.2 to 20.5 ng/mL) and median global myocardial
ECV was 29 % (interquartile range 26 to 33 %) in the
study population. There was a significant correlation
between Galectin-3 levels and global myocardial ECV (r =
0.50; p < 0.05). In contrast, no significant correlation was
found between Galectin-3 levels and LV end-diastolic
volumes (r = -0.08; p = ns), LV end-systolic volumes (r =
0.06; p = ns), LV stroke volumes (r = -0.33; p = ns); LV
ejection fractions (r = -0.11; p = ns), Troponin T levels
(r = 0.20; p = ns) or NT-proBNP levels (r = 0.28; p = ns),
respectively.
Conclusions
Myokardial ECV expansion, as a surrogate for myocar-
dial injury, is associated with increased Galectin-3 levels,
indicating activated fibrogenesis in patients with myo-
carditis. Combining Galectin-3 measurements with
ECV-imaging could improve risk stratification beyond
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